Family · Pharmaceutical analytical standards
Labetalol
An antihypertensive that blocks both beta and alpha-1 adrenergic receptors, patented in 1966 and in use since 1977: it is particularly indicated for high blood pressure in pregnancy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?It has two chiral centres and the medicine is a mixture of four stereoisomers: one blocks alpha-1 receptors, another blocks beta receptors, while the other two are practically inactive.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
